Tag: Alzheimer’s
Effect of Noradrenergic Drugs Explored in Alzheimer Disease
Meta-analyses suggest positive effects of noradrenergic drugs on global cognition, apathy
Changes in Alzheimer Biomarkers Tied to Withdrawal of PAP for OSA
Increase in neurofilament light, decrease in Aβ40 associated with withdrawal of positive airway pressure for obstructive sleep apnea
Reduction in Vial Size of Aducanumab Could Yield Savings
Savings would range from $70.9 to $369.0 million annually if the 300 mg/3.0 mL vial was reduced to 100 mg/1.0 mL
Financial Altruism May Indicate Cognitive Decline in Seniors
Financial altruism negatively associated with performance on cognitive measures known to be sensitive to early Alzheimer disease
Prevalence of LATE-NC Explored in Seniors, Alzheimer Disease
Almost 40 percent of those with ADNC had limbic-predominant age-related TDP-43 encephalopathy neuropathologic change
New Alzheimer Disease Drug Delivers Disappointing Results
Trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition
Medicare Spending Spikes for Dementia Diagnoses in Seniors
Medicare spending higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment
Prevalence of Risk Factors for Alzheimer, Related Dementias Identified
Highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity
Choroid Plexus Volume Up With Advanced Cognitive Impairment
Larger volume associated with severity of cognitive impairment across Alzheimer disease spectrum
One in Three Alzheimer, Dementia Cases Tied to Modifiable Risk Factors
Risk factors differ based on sex and race and ethnicity